A study links maternal use of cholesterol-inhibiting medications during pregnancy to increased autism risk in children, urging caution in prescribing practices.

The researchers focused on a class of medications called sterol biosynthesis-inhibiting medications, or SBIMs, which are often used to treat conditions like high cholesterol, certain infections, and some respiratory problems.